MedPath

Effects of saffron extract and its two main carotenoids (crocin, crocetin) on coronary heart disease

Phase 2
Conditions
Coronary Heart Disease.
Atherosclerotic heart disease
Registration Number
IRCT201512102017N26
Lead Sponsor
Vice-chancellor for Research of Tabriz University of Medical Sciences, Nutrition Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

overweight and obese patients with coronary heart disease; lack of cancers; autoimmune diseases and infectious; lack of allergy; no history of antioxidant supplements during the past six months; willingness to participate in this research project
Exclusion criteria: Any MI; Catching any infectious disease during the study; Menopause; pregnancy and lactation; expose with any side effects during the study; Unwillingness to continue participation in the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sirtuin-1 expression. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: real time-PCR.;AMPK expression. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: real time-PCR.;NF-kappa B expression. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: real time-PCR.;MCP-1 expression. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: real time-PCR.;Plasma levels of MCP-1. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: elisa (ng/ml).;Lipid profile variables. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: measurements of TC, LDL-c, HDL-c, TG by autoanalyzer.
Secondary Outcome Measures
NameTimeMethod
Quality of life score. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: Mac new quality of life questionnaire.;Food intake. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: three days food records.;Appetite levels. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: visual analouge scale.;Anthropometric indices. Timepoint: at baseline and after 2 months at the end of study. Method of measurement: measurements of height, waist and hip circumference with tape measure , weight with Seca scale.
© Copyright 2025. All Rights Reserved by MedPath